
Tailor Bio is a techbio platform focused on developing targeted therapies for cancers with Chromosomal Instability (CIN). CIN is a genomic phenomenon found in 80% of all cancers, often leading to more aggressive disease and poorer prognosis. Tailor Bio aims to make precision medicine a reality for these cancers, leveraging a team with expertise from leading institutions and biotech experience.

Tailor Bio is a techbio platform focused on developing targeted therapies for cancers with Chromosomal Instability (CIN). CIN is a genomic phenomenon found in 80% of all cancers, often leading to more aggressive disease and poorer prognosis. Tailor Bio aims to make precision medicine a reality for these cancers, leveraging a team with expertise from leading institutions and biotech experience.
Founded: 2019
Headquarters: London, United Kingdom
Focus: AI-driven discovery of targeted therapies for cancers with Chromosomal Instability (CIN)
Known funding: Seed round (Nov 23, 2022); investor: Acequia Capital
Team size (approx.): 20 employees
Cancer therapeutics (precision medicine for CIN-positive cancers)
2019
Biotechnology
“Acequia Capital (AceCap) listed as investor”